Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice

Vaccine

Volumn 16, Issue 7, 1998, Pages 692-697

  Erb, Klaus J ^a,d   Kirman, Joanna ^a   Woodfield, Lauren ^a   Wilson, Theresa ^b   Collins, Desmond M ^b   Watson, James D ^c   LeGros, Graham ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b Agriculture Research Institute   (New Zealand)

^c Genesis Research & Development Corporation Ltd   (New Zealand)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CD8 epitopes; DNA injection; Mycobacterium tuberculosis

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; COMPLEMENTARY DNA;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; EXPRESSION VECTOR; IMMUNOGENICITY; MOUSE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BCG VACCINE; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PEROXIDASES; VACCINES, DNA;

EID: 0032054150     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00253-3     Document Type: Article

References (14)

1. 1 Bloom, B.R. and Murray, J.L. Tuberculosis: commentary on a reemergent killer. Science 1992, 257, 1055-1064.
2. 2 Flynn, J.L., Chan, J., Triebold, K.J., Dalton, D.K., Stewart, T.A. and Bloom, B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993, 178, 2249-2253.
3. 3 Cooper, A.M., Dalton, D.K., Stewart, T.A., Griffin, J.P., Russell, D.G. and Orme, I.M Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 1993, 178, 2243-2248.
4. 4 Flynn, J.L., Goldstein, M.M., Triebold, K.J., Koller, B.B. and Bloom, B.R. Major histocompatibitity complex class I-restricted T cells are required tor resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 1992, 89, 12013-12017.
5. 5 Ladel, C.H., Daugelat, S. and Kaufmann, S.H. Immune response to Mycobacteriurn bovis bacille Calmette Guerin infection in major histocompatibility complex class I-and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 1995, 25, 377-384.
6. 6 Mescher, M.F. Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes. Immunol. Rev. 1995, 146, 177-210.
7. 7 Harris, D.P., Vordermeier, H.M. and Roman, E. et al. Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacteriurn leprae. J. Immunol. 1991, 147, 2706-2712.
8. 8 Ashbridge, K.R., Prestidge, R.L., Booth, R.J. and Watson, J.D. The mapping of an antibody-binding region on the Mycobacterium tuberculosis 19 kilodalton antigen. J. Immunol. 1990, 144, 3137-3142.
9. 9 Wilson, T.M. and Collins, D.M. ahpc, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 1996, 19, 1025-1028.
10. 10 Vogel, F.R. and Sarver, N. Nucleic acid vaccines Clin. Microbiol. Rev. 1995, 8, 406-410.
11. 11 Krishnan, S., Haensler, J. and Meulien, P. Paving the way towards DNA vaccines. Nature Med. 1995, 1, 521-522.
12. 12 Rammensee, H.G., Falk, K. and Rotzschke, O. Peptides naturally presented by MHC class I molecules. Ann. Rev. Immunol. 1993, 11, 213-244.
13. 13 Matzinger, P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Meth. 1991, 145, 185-192.
14. 14 Tascon, R.E., Colston, M.J., Ragno, S., Stavropoulos, E., Gregory, D. and Lowrie, D.B. Vaccination against Tuberculosis by DNA injection. Nature Med. 1996, 2, 888-891.